Abstract
BackgroundRo52/TRIM21 is a major target of autoantigenic responses in Sjögren’s syndrome (SS). Up-regulated epithelial Ro52 expression has been reported at the salivary gland inflammatory lesions of SS patients; however, the...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have